D-0009-2022 Class I Terminated

Recalled by Eli Lilly & Company — Indianapolis, IN

Recall Details

Product Type
Drugs
Report Date
October 20, 2021
Initiation Date
September 24, 2021
Termination Date
September 6, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19,174 syringes

Product Description

Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe. Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285; Glucagon, NDC: 0002-8031-01

Reason for Recall

SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration.

Distribution Pattern

Nationwide with the USA and Puerto Rico; Canada, Argentina, Costa Rica, Mexico

Code Information

Lot #: D239382D, Exp. Date April 2022